Fresenius Medical Care AG & Co. KGaA reported earnings results for the second quarter and six months ended June 30, 2022. For the second quarter, the company reported revenue was EUR 4,757 million compared to EUR 4,320 million a year ago. Net income was EUR 147 million compared to EUR 219 million a year ago. Basic earnings per share from continuing operations was EUR 0.5 compared to EUR 0.75 a year ago.
For the six months, revenue was EUR 9,305 million compared to EUR 8,530 million a year ago. Net income was EUR 305 million compared to EUR 468 million a year ago. Basic earnings per share from continuing operations was EUR 1.04 compared to EUR 1.6 a year ago.